EIF2AK2 and leukemia: VPA pre-treatment suppressed the transcription of IFN-stimulated anti-viral genes such as signal transducers and activators of transcription 1 (STAT1), protein kinase R (PKR) and promyelocytic leukemia (PML), thereby enhancing HSV gene expression, propagation and cytotoxicity.